Clinical characteristics and diagnosis and treatment experiences of Langerhans cell histocytosis in skull
10.3760/cma.j.cn115354-20200901-00701
- VernacularTitle:颅骨朗格汉斯组织细胞增生症的临床特点及诊疗体会
- Author:
Guoyang YIN
1
;
Cuicui LIU
;
Yilei XIAO
;
Haitao JIANG
;
Chongfu XU
;
Zhiyu GAO
;
Zipeng ZHU
;
Fenghai YANG
;
Qiang FU
Author Information
1. 聊城市人民医院脑科医院神经外科 252000
- Keywords:
Langerhans cell histiocytosis;
Skull;
Clinical review
- From:
Chinese Journal of Neuromedicine
2021;20(5):495-500
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the clinical characteristics and diagnosis and treatment experiences of Langerhans cell histocytosis (LCH) in skull.Methods:Sixteen patients with cranial LCH admitted to our hospital from January 2015 to December 2019 were chosen in our study. Their clinical data, diagnosis and treatment procedures and prognoses were retrospectively analyzed.Results:Among the 16 patients, there were 13 males and 3 females, aged from 1 to 31 years. The clinical manifestations included space-occupying lesions of the skull; and imaging showed bone destruction of the skull, with or without involvement of other bones or organs. All patients were pathologically confirmed to have LCH after surgical total resection of the lesions. Routine whole-body bone scanning was performed after surgery: one was found to have local abnormal metabolic activity and received local radiotherapy; 8 were combined with other bone or organ involvement, and received chemotherapy. All the patients were followed up for 1-5 years, and no recurrence was found, and no one died.Conclusion:Good prognosis can be achieved in cranial LCH patients accepted resection by giving additional treatment according to the results of postoperative reexamination and combination use of standardized radiotherapy and chemotherapy.
